Renovaro Biosciences Inc.
0.81
-0.01 (-0.75%)
At close: Jan 15, 2025, 1:40 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY12 FY11 FY10
Cash & Equivalents 220.47K 1.87M 9.17M 20.66M 8.70M 12.28M 15.60M 3.94M 23.37K 3.01M 6.74K 336.00 n/a
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a 196.14K n/a n/a n/a n/a n/a
Other Long-Term Assets 19.85K 21.74K 68.64K 20.98K 137.55K 155.05M 155.07M 127.13K 138.35K 7.15K n/a n/a n/a
Receivables 1.11M n/a n/a 1.64K 1.98K 20.79K 122.87K 223.78K 695.42K 8.02K 13.22K 13.22K n/a
Inventory n/a n/a n/a -1.64K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 668.93K 690.92K 393.00K 232.94K 244.85K 191.97K 38.28K 33.39K 13.69K 2.03M n/a n/a n/a
Total Current Assets 2.00M 2.57M 9.57M 20.90M 8.94M 12.49M 15.76M 4.20M 732.48K 5.05M 19.96K 13.55K n/a
Property-Plant & Equipment 1.75M 1.42M 1.74M 2.16M 2.48M 687.52K 27.40K n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles 159.36M 54.29M 73.26M 166.53M 166.54M 11.64M 11.64M n/a n/a 186.41K n/a n/a n/a
Total Long-Term Assets 161.13M 55.74M 75.07M 168.71M 169.16M 167.38M 166.74M 323.27K 138.35K 193.56K n/a n/a n/a
Total Assets 163.13M 58.30M 84.63M 189.61M 178.10M 179.88M 182.50M 4.52M 870.83K 5.24M 19.96K 13.55K n/a
Account Payables 9.45M 5.30M 1.40M 320.56K 592.88K 538.56K 806.81K 434.97K 1.19M 923.89K n/a n/a n/a
Deferred Revenue 231.38K 723.17K 1.03M 1.18M n/a n/a n/a 1.00 n/a n/a n/a n/a n/a
Short-Term Debt 2.94M 5.00M 1.45M 292.41K 271.29K n/a n/a 2.09M 102.88K 99.95K 63.73K 27.23K n/a
Other Current Liabilities 17.92M 723.17K 3.60M 1.27M 470.64K 571.85K 66.91K 464.60K 220.23K 733.83K 7.50K n/a 8.73K
Total Current Liabilities 30.31M 11.02M 6.45M 1.89M 1.33M 1.11M 873.72K 2.99M 1.51M 1.76M 71.23K 27.23K 8.73K
Long-Term Debt 842.39K 775.59K 5.56M 7.02M 7.31M n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a 6.04M 3.18M 5.67M 22.89M n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities 842.39K 775.59K 5.56M 13.06M 10.49M 5.67M 22.89M n/a n/a n/a n/a n/a n/a
Total Liabilities 31.15M 11.80M 12.01M 14.94M 11.83M 6.78M 23.76M 2.99M 1.51M 1.76M 71.23K 27.23K 8.73K
Total Debt 3.79M 5.59M 7.02M 7.31M 7.58M n/a n/a 2.09M 102.88K 99.95K 63.73K 27.23K n/a
Common Stock 15.50K 6.37K 5.30K 5.22K 4.65K 4.53K 3.62K 1.24K 953.00 953.00 500.00 500.00 500.00
Retained Earnings -324.68M -244.03M -204.35M -90.91M -64.19M -52.77M -34.76M -28.44M -26.30M -21.89M -76.27K -38.68K -8.73K
Comprehensive Income -170.85K -29.88K -30.44K -10.83K -41.42K 101.82K 205.68K 352.83K 564.29K 275.25K n/a n/a n/a
Shareholders Equity 131.98M 46.50M 72.62M 174.66M 166.27M 173.10M 158.74M 1.53M -637.40K 3.48M -51.27K -13.68K -8.73K
Total Investments n/a n/a n/a n/a n/a n/a n/a 196.14K n/a n/a n/a n/a n/a